Slower than expected government orders for AIDS drugs and unreliable water supplies has knocked production at pharmaceutical manufacturer Adcock Ingram’s local factories, amplifying the effect of weak consumer demand and rising costs that saw the company deliver a mere 1% increase in headline earnings.
Revenue rose 1% to R3.63bn in the six months to end-December 2019, compared to R3.59bn in the corresponding period the year before, while operating profit increased at the same rate to R462m, up from R457m the year before.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IOL - 🏆 46. / 51 Read more »
MARK GEVISSER: From apartheid, Aids and now the climate crisis: how do we change SA’s tradition of denial?MARK GEVISSER: From apartheid, Aids and now the climate crisis: how do we change SA’s tradition of denial? 🔒 MarkGevisser
Source: BDliveSA - 🏆 12. / 63 Read more »
MARK GEVISSER: From apartheid, Aids and now the climate crisis: how do we change SA’s tradition of denial?MARK GEVISSER: From apartheid, Aids and now the climate crisis: how do we change SA’s tradition of denial? 🔒 MarkGevisser
Source: BDliveSA - 🏆 12. / 63 Read more »
Source: IOL - 🏆 46. / 51 Read more »
CHRIS GILMOUR: Outlook remains bleak for SA economyEconomists are concerned by slow progress and are not optimistic on growth and job creation Wow, now that's surprizing?
Source: BDliveSA - 🏆 12. / 63 Read more »
CHRIS GILMOUR: Outlook remains bleak for SA economyEconomists are concerned by slow progress and are not optimistic on growth and job creation
Source: BDliveSA - 🏆 12. / 63 Read more »